N/A
Manufactured by Novo Nordisk
37,587 FDA adverse event reports analyzed
Last updated: 2026-05-19
Wegovy is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Novo Nordisk. The most commonly reported adverse reactions for Wegovy include NAUSEA, VOMITING, DIARRHOEA, OFF LABEL USE, FATIGUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for Wegovy.
Out of 19,946 classified reports for Wegovy:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 37,587 FDA FAERS reports that mention Wegovy. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include NAUSEA, VOMITING, DIARRHOEA, OFF LABEL USE, FATIGUE, CONSTIPATION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Novo Nordisk in connection with Wegovy. Always verify the specific product and NDC with your pharmacist.
Explore other medications manufactured by Novo Nordisk and compare their safety profiles:
The following drugs share commonly reported adverse reactions with Wegovy: